A Delaware federal judge has ruled that a planned generic from Teva Pharmaceuticals infringes on a patent on Vifor Fresenius Medical Care Renal Pharma’s Velphoro (sucroferric oxyhydroxide), a chewable tablet that’s used to control phosphate levels in the blood of chronic kidney disease patients on dialysis.
Source: Drug Industry Daily